This article refers to:
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M. The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer. OncoTargets and Therapy. 2017;10:1735–1742.
The authors have advised us of concerns about the specificity of the primary antibody which have resulted in misleading and false results.